|
BYSL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.412600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.238800E-01 |
| Normal-vs-Stage2 |
4.500600E-01 |
| Normal-vs-Stage3 |
8.160200E-01 |
| Normal-vs-Stage4 |
4.654800E-01 |
| Stage1-vs-Stage2 |
1.062030E-01 |
| Stage1-vs-Stage3 |
5.862800E-01 |
| Stage1-vs-Stage4 |
8.841400E-01 |
| Stage2-vs-Stage3 |
4.035000E-01 |
| Stage2-vs-Stage4 |
2.004200E-01 |
| Stage3-vs-Stage4 |
6.376000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.860200E-01 |
| Normal-vs-AfricanAmerican |
8.148200E-01 |
| Normal-vs-Asian |
8.287600E-01 |
| Caucasian-vs-AfricanAmerican |
9.565200E-01 |
| Caucasian-vs-Asian |
9.955200E-01 |
| AfricanAmerican-vs-Asian |
9.548400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.335800E-01 |
| Normal-vs-Female |
7.749200E-01 |
| Male-vs-Female |
2.077600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.412400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.205440E-01 |
| Normal-vs-Age(61-80Yrs) |
4.580200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.636790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.950600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.232400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.242410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.676020E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.976000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.105800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.934600E-01 |
| Classical-VS-Follicular |
2.188200E-01 |
| Classical-VS-Other |
1.895830E-01 |
| Classical-VS-Normal |
7.676800E-01 |
| Tall-VS-Follicular |
1.446430E-01 |
| Tall-VS-Other |
1.996960E-01 |
| Tall-VS-Normal |
5.933400E-01 |
| Follicular-VS-Other |
3.634600E-01 |
| Follicular-VS-Normal |
2.392600E-01 |
| Other-VS-Normal |
3.370800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.477000E-01 |
| Normal-vs-N1 |
5.112400E-02 |
| N0-vs-N1 |
3.092000E-02 |
|
|
